Search for: "Mylan, Inc."
Results 161 - 180
of 673
Sort by Relevance
|
Sort by Date
26 Dec 2017, 7:08 pm
Mylan paid approximately $231.7 million to the federal government and $213.9 million to state Medicaid programs. [read post]
19 Dec 2017, 3:13 pm
Mylan Labs., Inc., 464F.3d 1286, 1289 (Fed. [read post]
5 Dec 2017, 7:40 am
Here are the amici curiae in the matter of Mylan Pharmaceuticals Inc. et al v. [read post]
1 Dec 2017, 2:53 pm
Mylan Laboratories Limited et al., Civil Action No. 16-224-LPS (D.Del., December 1, 2017), the Court denied without prejudice the motion to dismiss for improper venue or, in the alternative, to transfer venue to the Northern District of West Virginia of Defendant Mylan Laboratories Limited, Mylan, Inc. and Mylan Pharmaceutical Inc. [read post]
30 Nov 2017, 5:26 am
Here is the amicus brief filed in Mylan Pharmaceuticals Inc. v. [read post]
11 Nov 2017, 11:00 am
Mylan Institutional LLC, 846 F.3d1213, 1221–23 (Fed. [read post]
1 Nov 2017, 2:58 pm
See, GE’s brief, for example, 16-712 bsac General Electric Company; also, 16-712 bsac BSA The Software Alliance; 16-712 bsac Unified Patents Inc.; and 16-712 bsac SAP America, Inc., et al. [read post]
1 Nov 2017, 7:15 am
Mylan Inc., et al, 1-11-cv-01285 (ILND October 30, 2017, Order) (St. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
25 Sep 2017, 3:59 am
Here is the brief in the matter captioned Mylan Pharmaceuticals Inc. v. [read post]
20 Sep 2017, 9:18 am
Mylan Pharmaceuticals Inc., a patent infringement matter brought under the Hatch-Waxman statute and filed before the TC Heartland decision, the parties did not dispute that, in light of TC Heartland, the defendant, a West Virginia corporation, could not be said to “reside” in Delaware. [read post]
13 Sep 2017, 7:44 am
Mylan Pharmaceuticals, Inc., 1-17-cv-00379 (DED September 11, 2017, Order) (Stark, USDJ) [read post]
11 Sep 2017, 5:35 pm
").CaseBRISTOL~MYERS SQUIBB COMPANY and PFIZER INC v, Mylan ["MPI"], 2017 U.S. [read post]
7 Sep 2017, 9:59 pm
Teleflex, Inc. (2007). [read post]
5 Sep 2017, 7:45 am
Mylan Inc. and Mylan Specialty L.P. are both wholly owned subsidiaries of Mylan N.V., which is headquartered in Canonsburg, Pennsylvania. [read post]
25 Aug 2017, 2:25 pm
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
25 Aug 2017, 7:02 am
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
25 Aug 2017, 7:02 am
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
20 Aug 2017, 7:14 am
Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. agree to pay $465 million to settle a lawsuit brought under the False Claims Act (FCA). [read post]
